Article Details
Retrieved on: 2022-12-28 09:54:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The CDMO partner of Stelis Biopharma Ltd. receives approval for a key 'abbreviated new drug application' from the U.S. FDA.
Article found on: www.bqprime.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here